Prot# SP-NON-0010: Phase II Study on Analgesic Efficacy, Safety & Tolerability of AR-P900758XX: A 6 Week, Rndmzd, Dbl-Bld, Placebo-Controlled, Dose-Finding, Mltctr Study Comparing AR-P900758XX w/ Vioxx® & w/ Naproxen in Subjects w/ Osteoarthritis of Knee

Project: Research project

Project Details

StatusFinished
Effective start/end date3/11/02 → 5/16/07

Funding

  • Rheumatology Research International (RRI) (SP-NON-0010)
  • AstraZeneca Pharmaceuticals LP (SP-NON-0010)